LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma

Stopped Study voluntarily stopped by Principal Investigator due to lack of accrual.

Conditions

• Ovarian Cancer
• Ovarian Carcinoma
• Recurrent Ovarian Cancer
• Recurrent Ovarian Carcinoma

Interventions

• RADIATION: Low Dose Fractionated Whole Abdominal Radiation Therapy
• DRUG: Docetaxel

Sponsor

University of Miami